Medios AGMEDOF 88 FCF Yield % is 16.84 as of Jun. 27, 2026, which is 149% above its 10-year median of 6.76. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $71.50. The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, Medios AG ranks better than 85.71% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medios AG FCF Yield % Related Terms
Medios AG FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medios AG's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medios AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medios AG's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG (MEDOF) has a FCF Yield % of 16.84 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medios AG and its competitors. This is 149% above median its historical median of 6.76. According to the industry distribution chart, Medios AG ranks #17 out of 119 companies in the Medical Distribution industry, placing it in the top 14.3%.
Is Medios AG's FCF Yield % too high?
Medios AG's current FCF Yield % of 16.84 is 149% above median its 10-year median of 6.76. The Medical Distribution industry median FCF Yield % is 2.63. Medios AG's value of 16.84 is 540.3% above this industry median. Based on the distribution chart, Medios AG ranks #17 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #17 out of 119 companies for FCF Yield %. This places Medios AG in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 2.63. Medios AG's value of 16.84 is 540.3% above this benchmark. While the company's 10-year median is 6.76 vs. the industry median of 2.63, Medios AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 2.63, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current FCF Yield % of 16.84 is 540.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median FCF Yield % is 2.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current FCF Yield % is 16.84, which is 149% above median its own 10-year median of 6.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current FCF Yield % of 16.84. The stock's GF Value™ is $71.50, compared to a current price of $50.00 — trading 30.1% below its estimated fair value. The current FCF Yield % is 16.84, which is 149% above median its 10-year median of 6.76 and 540.3% above the Medical Distribution industry median of 2.63. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medios AG (MEDOF), the current FCF Yield % is 16.84 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.
Key valuation signals for MEDOF:
FCF Yield %: 16.84 (149% above median its 10-year median of 6.76)
GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
Industry Position: 540.3% above the Medical Distribution median (#17 of 119)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
